WIRE

WIRE is funded by AstraZeneca, led by CI Grant Stewart, and sponsored by Cambridge University Hospitals NHS Foundation Trust.

It is a a phase 2, multi-arm, multicentre, non-randomised, proof-of-mechanism trial using a Bayesian adaptive design.

You can find out more here, or from WIRE’s registration on ClinicalTrials.gov.